Pharmafile Logo

Purpose-driven

- PMLiVE

The words around health matter

The language used in healthcare can influence how people perceive their health, feel about themselves, and engage with treatments. Whole-person communication can help reduce stigma and support better real-world healthcare...

Mednet

- PMLiVE

The real-world challenge pharma can’t ignore: Sustained engagement

Breakthrough therapies do not fail because the science stops working. They fail when healthcare is not designed for the physical, emotional and mental realities shaping how people engage with treatment...

Mednet

- PMLiVE

Where Making Health Whole began

Mental health providers revealed years ago what healthcare is only now beginning to recognise: information alone does not sustain engagement. This article explores how Mednet’s heritage in mental health has...

Mednet

Site Factor report illustrations

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

Cuttsy + Cuttsy

HCP talking to patients

Designing with patients in mind: How to build more inclusive clinical trials

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

Cuttsy + Cuttsy

Mother playing with son

Using patient personas to add a personal touch to clinical trial recruitment and retention

Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.

Cuttsy + Cuttsy

Investors in People Platinum logo

Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

Cuttsy + Cuttsy

- PMLiVE

BOLDADVOCACY Division of BOLDSCIENCE Strengthens Leadership Team with Tori Fahrney

BOLDSCIENCE, One of the Fastest-Growing Firms in the Health Care Sector, and the Minds + Assembly Platform Reinforce Importance of Supporting Patients and Caregivers

BOLDSCIENCE

- PMLiVE

What are “orphan drugs” and how do we navigate the challenges of writing about them?

The first in our 'Ask Alex' series, where Principal Medical Writer, Dr Alexandra Loveday answers some frequently asked questions about Medcomms. This week, she takes a look at 'orphan drugs',...

Mednet

- PMLiVE

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

Resonant Group

Imagery icons in Cuttsy+Cuttsy branded shapes

Clinical trials explained: Why imagery matters…

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Cuttsy + Cuttsy

- PMLiVE

BOLDSCIENCE launches BOLDAPPROVALS division

BOLDAPPROVALS, a new division of the medical communications agency BOLDSCIENCE, will help pharmaceutical and biotech clients gain regulatory approval with comprehensive services that include preparation for US Food and Drug...

BOLDSCIENCE

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links